Mayne Pharma Boosts Board with Rivera

Mayne Pharma’s board just got a powerhouse upgrade with Meghan Rivera’s appointment—bringing 25+ years of top-tier US pharma experience to steer the company through competitive waters. While the broader market stumbled, Mayne soared alongside Spacetalk, Terramin, and others, proving strategic hires and strong fundamentals can shine even when the winds blow against the pack. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/7463008a789e2a7e